Dr. Silvia Martins[/caption]
Silvia S. Martins, MD, PHD
Associate Professor of Epidemiology
Department of Epidemiology
Mailman School Of Public Health
Columbia University
New York, NY 10032
MedicalResearch.com: What is the background for this study?
Response: Given the high probability of nonmedical use among adolescents and young adults, the potential development of prescription opioid use disorder secondary to nonmedical use among youth represents an important and growing public health concern. Still, no study had investigated time trends, specifically if prescription opioid use disorder has increased in the past decade among adolescents, emerging adults and young adults who are nonmedical users of prescription opioids.
Dr. Eric Jacobs[/caption]
Eric Jacobs, PHD
Strategic Director, Pharmacoepidemiology
American Cancer Society, Inc.
250 Williams St.
Atlanta, GA 30303
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Vasectomy is a common, inexpensive, and very effective method of long-term birth control. However, in 2014, an analysis from a large epidemiologic cohort study, the Health Professionals Follow-Up Study, found that vasectomy was associated with about 10% higher overall risk of prostate cancer and about 20% higher risk of fatal prostate cancer. Together with other researchers at the American Cancer Society, I analyzed the association between vasectomy and fatal prostate cancer among more than 363,000 men in the Cancer Prevention Study II (CPS-II) cohort, age 40 and older, who were followed for up to 30 years. This is the largest prospective analysis of vasectomy and fatal prostate cancer to date. We also examined vasectomy and prostate cancer in a subset of about 66,000 CPS-II study participants who were followed for new diagnoses of prostate cancer.
We found no link between having had a vasectomy and risk of either developing or dying from prostate cancer.
Dr. Nataniel Lester-Coll[/caption]
Nataniel Lester-Coll, MD
Chief Resident in Radiation Oncology at Yale
New Haven, Connecticut
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Recurrent Glioblastoma Multiforme (GBM) has limited treatment options and the prognosis is poor. Mibefradil diydrochloride was identified using a high-throughput compound screen for DNA double stranded break repair inhibitors. Mibefradil was found to radiosensitize GBM tumor cells in vitro and in vivo. Based on these findings, we sought to determine the maximum tolerated dose of mibefradil and radiation therapy in a Phase I recurrent GBM study. Eligible patients with recurrent Glioblastoma Multiforme received Mibefradil over a 17 day period, with hypofractionated radiation (600 cGy x 5 fractions). There are 18 patients currently enrolled who have completed treatment. Thus far, there is no clear evidence of radionecrosis. A final dose level of 200 mg/day was reached as the maximum tolerated dose. The drug was very well tolerated at this dose. We saw intriguing evidence of enhanced local control in selected cases. Patients enrolled in a translational substudy who received Mibefradil prior to surgery were found to have adequate levels of Mibefradil in resected brain tumor tissue.
Dr. Paola Scaffidi[/caption]
Paola Scaffidi, PhD
Group Leader
Cancer Epigenetics Laboratory
The Francis Crick Institute
London
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Every cancer is different, but even within the same tumor cells are highly diverse, and only some of them are truly immortal and drive tumor growth. This is quite surprising if we think that cancer arises from one cell that keeps replicating itself. So why are some cancer cells more dangerous than others? And why do some cells "get tired" along the way and, at some point, stop dividing?
In our study we describe one cellular mechanism that provides some answers to these questions. We have found that to be able to divide indefinitely, cancer cells have to strongly reduce the levels of a nuclear protein called histone H1.0. This is needed to allow activation of many genes important for cancer cell proliferation, which otherwise would be somehow "hidden" within the cell nucleus. Importantly, though, while tumors grow, some cells raise back the levels of H1.0, which hides these genes again and makes the cells stop proliferating. So the end result is that within the same tumor we have a mix of cells, some which keep these important genes on, while others switch them off and, as a consequence, lose their ability to divide, and differentiate into a more mature state.
Dr. Melissa Bartick[/caption]
Melissa C. Bartick, M.D.
Assistant Professor of Medicine
Department of Medicine, Cambridge Health Alliance, Cambridge
Harvard Medical School, Boston
Massachusetts
MedicalResearch.com: What is the background for this study?
Response: There has never been a study that combined maternal and pediatric health outcomes and costs into a single model. My colleague Arnold Reinhold and I had published a pediatric study in 2010, which was widely publicized but needed to be updated. My colleagues and I published a maternal study in 2013. But the two studies had different methodologies, and so the total costs could not be simply added together.
Here, we wanted to get a picture of the impact of breastfeeding in the US public health as whole, by creating a single model that combined maternal and pediatric outcomes. That had never been done before.
Dr. Adam Brufsky[/caption]
Adam Brufsky, MD, PhD, FACP
Medical Director of the Women's Cancer Center
University of Pittsburgh Medical Center
MedicalResearch.com: What is the background for this study? What are the main findings?
Kimberly G. Harmon, MD
University of Washington
Seattle, WA 98195.
MedicalResearch.com: What is the background for this study?
Response: Sudden cardiac death (SCD) in a young athlete is tragic devastating families and communities. It has been characterized as “rare” by some, however, previous studies have looked at broad age ranges of athletes and used various methods to determine the incidence rate, sometimes only including athletes which have events during school sponsored events. In addition, many studies only look at sudden cardiac death and do not include sudden cardiac arrest (SCA) where the athlete has a cardiac arrest but is resuscitated and survives. SCA is important to include as ideally we would like to prevent both SCA and SCD in athletes. In this paper, over 1/3 of all US high school athletes were studied for six years to determine the incidence and the causes of SCA/D. Media reports were used to identify cases and then autopsies were obtained in those who died.
Prof. Kourosh Kalantar-Zadeh[/caption]
Distinguished Professor Kourosh Kalantar-Zadeh
RMIT's School of Engineering
Australia
MedicalResearch.com: What is the background for this study? What are the main findings?
1- The development of "swallow-able gas sensor capsules". This was the final test on animals and focused on the measurement of a food supplement (cinnamon) to show the extraordinary capability of this noninvasive tool that will revolutionise the future of Gastroenterology and Food Sciences
2- That cinnamon can improve the health of the stomach, and hence our overall health, by adjusting the acidity and enzymatic secretion in the stomach. So the good effect of cinnamon is not just a grandparent old advice - It is real.
Dr. Johan Frostegård[/caption]
Dr. Johan Frostegård MD PhD
Professor of medicine
Karolinska Institutet's Institute of Environmental Medicine and
Consultant at Karolinska University Hospital's Emergency Clinic
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Statins are one of the worlds most sold medications, which has generated large profits, but also, in my opinion, helped many people. Still, side effects are much discussed after more than 2 decades of use, as exemplified by a current debate between Lancet and BMJ (the former has the opinion that side effects are not major issues, but the latter do not agree). Also the exact role of LDL (low density lipoprotein, also known as the ”bad cholesterol”) as a risk factor is discussed, and can vary, according to many researchers. LDL levels are important among middle aged persons, especially men, as a risk markers for cardiovascular disease, especially myocardial infarction. LDL is most likely less important as a risk factor in individuals above 60 years of age, and also among women – as compared to middle aged men.
Dr. Hadine Joffe[/caption]
Hadine Joffe, MD, MSc
Associate Professor of Psychiatry, Harvard Medical School
Vice Chair for Psychiatry Research
Director of Division of Women's Mental Health / Dept of Psychiatry / Brigham and Women’s Hospital
Director of Psycho-Oncology Research / Dept of Psychosocial Oncology and Palliative Care /Dana Farber Cancer Institute
www.brighamwharp.org
MedicalResearch.com: What is the background for this study?
Response: We conducted this study to advance our understanding about causes of mood disturbance in the menopause transition that are specifically related to menopause. We used an experimental model to dissect out the contributions of hot flashes and sleep disturbance from contribution of changing levels of estrogen because hot flashes, sleep problems, and estrogen fluctuations co-occur and are difficult to distinguish from one another. Understanding whether hot flashes and/or sleep disturbance are causally related to mood disturbance will help us identify who is at risk for mood changes during the menopause transition. This is incredibly important now that we are finding effective non-hormonal treatments for hot flashes and sleep disruption.
Dr. Kenneth K. Mugwanya[/caption]
Kenneth K. Mugwanya MBChB, MS
Department of Epidemiology andDepartment of Global Health
University of Washington, Seattle, Washington, USA
Division of Disease Control, School of Public Health
Makerere University
Kampala, Uganda
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Women living in regions with high HIV prevalence are at high risk of HIV acquisition in pregnancy and postpartum because they infrequently use condoms, do not know their partner's HIV status, and have biologic changes or changes in their partner's sexual partnerships that increase susceptibility. Moreover, acute HIV infection during pregnancy or breastfeeding period is associated with high rates of mother-to child HIV transmission because of high circulating level of HIV virus in blood. Oral antiretroviral pre-exposure prophylaxis (PrEP) is a powerful HIV prevention strategy recommended by both the World Health organization and US Centers for Diseases Control and Prevention. PrEP is an attractive prevention strategy for women as it can be used discreetly and independent of sexual partners. However, there is limited research about the safety of PrEP in HIV-uninfected pregnant or breastfeeding mothers and their infants.
Prof. Adrian Woolf[/caption]
Prof Adrian S. Woolf
Chair, Professor of Paediatric Science
University of Manchester, UK
MedicalResearch.com: What is the background for this study?
Response: Several years ago, Laurent Fasano discovered that the Drosophila teashirt gene was needed to pattern the body of embryonic flies.
He then found that this transcription factor had three similar genes in mammals.
Working with Adrian Woolf in the UK, they found that Teashirt-3 (Tshz3) was needed in mice to make muscle form in the ureter When the gene was mutated, mice were born with ureters that were 'blown-up' and they failed to milk urine from the kidney with the bladder.
Dr. Eric P Skaar,[/caption]
Eric P Skaar, Ph.D., MPH
Director, Division of Molecular Pathogenesis
Ernest W. Goodpasture Professor of Pathology
Vice Chair for Basic Research, Department of Pathology, Microbiology, and Immunology
Vanderbilt University School of Medicine
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Nutrient metals are known to be a critical driver of the outcome of host-pathogen interactions, and C. difficile is the most common cause of hospital-acquired infections. C. difficile infection typically occurs following antibiotic-mediated disruption of the healthy microbiome. We were interested in learning how nutrient metals can shape the microbiome and impact the outcome of Clostridium difficile infection.
We found that excess zinc alters the structure of the microbiome and increases the severity of C. difficile infection in mice.
Dr. Bashir Lwaleed[/caption]
Dr. Bashir A. Lwaleed PhD, FRCPath, PGCAP, FHEA, CBiol FSB, FIBMS
Faculty of Health Sciences
University of Southampton
South Academic and Pathology Block (MP 11)
Southampton General Hospital
Southampton UK
MedicalResearch.com: What is the background for this study?
Response: The study merges two longstanding interests. We have long worked out of several departments at Southampton and Portsmouth on the therapeutic potential for natural products (including the medium – chain fatty acids GLA (evening primrose oil) and EPA (fish oil) as well as honeys from a number of floral sources. Secondly, there is an established research theme in the Faculty of Healthcare Science at Southampton addressing continence related issues; moreover catheter management as an economic and infection control issue is a major concern in the NHS Trust Urology department. Biofilms on catheters are sources of infection, honey has proven antibacterial (and other therapeutic) properties in topical applications such as skin ulceration. It is a logical step to assess whether a similar use may be made for honey instilled into the bladder and/or flushing the lumen of a catheter.
Dr. Kanu Okike[/caption]
Kanu Okike MD MPH
Department of Orthopaedic Surgery, Kaiser Moanalua Medical Center
Honolulu, Hawaii
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Many journals in the social sciences practice double-blind review, in which reviewers and authors are both blinded to each others' identities. In medicine, on the other hand, most journals practice single-blind review, in which authors' identities are known to reviewers. Concerns have been raised that this could lead to biased reviews, however, especially in the case of well-known authors.
In our study, we composed a fabricated test manuscript and randomized reviewers for an orthopaedic journal to receive single-blind (prestigious authors listed) or double-blind (no authors listed) versions. In our study, the reviewers who were under the impression that the manuscript was written by prestigious authors (single-blind review) awarded higher marks and also recommended acceptance more often, in spite of the fact that the manuscripts were otherwise identical.
Dr. Thomas M. Gill[/caption]
Thomas M. Gill, M.D.
Humana Foundation Professor of Geriatric Medicine
Professor of Medicine, Epidemiology & Investigative Medicine
Director, Yale Program on Aging/Pepper Center
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Maintaining independent mobility is an important goal of clinical medicine and public health, especially among older persons, who are at the greatest risk for disability.
By adopting a walking routine and other moderate physical activities, older adults can recover from a major disability more quickly, and maintain their independence over time.
Dr. Michael Hill[/caption]
Dr. Michael Hill, MSc, MD, FRCPC
Professor for the Departments of Clinical Neurosciences, Community Health Sciences, Medicine and Radiology University of Calgary
Director of the Stroke Unit
Calgary Stroke Program
Alberta Health Services
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: The HERMES collaboration is a pooled individual patient meta-analysis of recent endovascular ischemic stroke trials. The current analysis assesses the role of time to treatment and outcome.
We show that there is a clear relationship between time from onset-to-treatment and outcome, with treatment gradually becoming less effective as time elapses from stroke onset. Treatment was still effect, on average, out to just beyond 7 hours from stroke onset.
Dr. Xabier Garcia-De-Albeniz[/caption]
Xabier Garcia-De-Albeniz MD PhD
Research Associate
Department of Epidemiology
Harvard T.H. Chan School of Public Health
Mongan Institute for Health Policy
Massachusetts General Hospital
MedicalResearch.com: What is the background for this study?
Response: Randomized controlled trials are considered the gold standard to inform health care delivery. Unfortunately, no randomized controlled trials of screening colonoscopy have been completed. Ongoing trials exclude persons aged 75 or older, and will not have mature results before 2025. However, healthy persons older than 75 may live long enough to benefit from colorectal cancer (CRC) screening. The Medicare program reimburses screening colonoscopy without an upper age limit since the year 2001. We used the extensive experience of Medicare beneficiaries to evaluate the effectiveness and safety of screening colonoscopy.
Dr. Ursula H. Winzer-Serhan[/caption]
Ursala. H. Winzer-Serhan Ph.D.
Associate Professor
Department of Neuroscience and Experimental Therapeutics
Texas A&M Health Science Center
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Nicotine is a plant alkaloid that is naturally occurring in the tobacco plant. Smoking delivers nicotine to the brain where it acts as a stimulant. Tobacco and electronic cigarette smoking delivers many other chemicals to the body, which are harmful and can cause cancer.
However, the drug nicotine by itself is relatively benign and poses few health risks for most people. Nicotine acts in the brain on nicotinic receptors, which are ion channels that are widely expressed in the brain. They play an important role in cognitive functions. Research with rodents and in humans has shown that nicotine can enhance learning and memory, and furthermore, can protect neurons during injuries and in the aging brain. With the increasingly older population, it becomes more and more important to delay cognitive decline in the elderly. Right now, there is no drug available that could delay aging of the brain.